COVID-19 tests are important, but so is mental health. Photo courtesy of Next Level Urgent Care

While the world's population has been focused on the physical effects of COVID-19, there hasn't always been as much attention paid to mental health amid the pandemic.

Every socio-economic class, demographic group, and industry has felt the strain, brought on by social isolation, job instability, and increased stress.

"It quickly became clear that these preventative measures, while recommended for reducing the spread of COVID-19 in the workplace, were not providing the feeling of security for company employees that we had hoped for," says Next Level Urgent Care's chief medical officer, Karen Rakers, MD. "We needed to address employee mental health."

Next Level Urgent Care began COVID-19 testing across its 15 urgent care locations in March, and shortly after expanded into Houston workplaces, providing onsite COVID-19 testing and temperature checks for large employers in the Houston area.

When it became clear that mental health required more attention than it had been getting, the Next Level Health and Wellness team worked with clinical psychologist Ilyssa Bass, PhD, to assemble a group of diverse mental health and workplace wellness professionals.

Together, they worked to address mental health stigma in the workplace and educate employers on how to implement creative solutions to address employee mental health issues.

One of the major results is the Prioritizing Workplace Wellness Summit, a free five-day virtual event taking place September 28-October 2.

Attendees can look forward to interviews with more than 25 interviews experts, including such as Sally Spencer-Thomas, Psy.D; Daryl Shorter, MD; Craig Kramer; Liz Kislik; Bill Judge, JD, LL.M; and Jeff Gorter, LMSW.

Here's a taste of what you'll discover during the summit:

  • How a multi-faceted approach to improving the mental health of an employee group leads to success
  • Which qualities make organizations resilient when responding to crises including the pandemic
  • Leadership skills and techniques that help maintain a strong workforce
  • Threat assessments and multidisciplinary workplace violence prevention programs to keep an employee group safe
  • How now, more than ever, technology can help reach the masses and deliver easily accessible solutions for common mental health issues
  • Steps employers can take to reduce stigma in their organizations
  • Why the time for action is right now during the pandemic

As a bonus, each free ticket also comes with access to an exclusive new report, "The Top Workplace Wellness and Mental Health Strategies."

Sign up to discover what's working today to optimize mental health in the workplace — your employees will thank you.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”